CV Sciences, Inc. (CVSI)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 7M 14M 21M Q3 '21: 20.3M Q4 '21: 20M Q1 '22: 19.7M Q2 '22: 18.7M Q3 '22: 17.3M Q4 '22: 16.2M Q1 '23: 15.9M Q2 '23: 15.7M Q3 '23: 16.1M Q4 '23: 16M Q1 '24: 15.9M Q2 '24: 15.8M Q3 '24: 15.6M Q4 '24: 15.7M Q1 '25: 15.3M Q2 '25: 15M Q3 '25: 14.4M Q4 '25: 13.8M Q1 '26: 13.4M Q2 '26: 12.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 3.5M 7M 10.5M Q3 '21: 9.2M Q4 '21: 8.6M Q1 '22: 7.4M Q2 '22: 6.4M Q3 '22: 5.6M Q4 '22: 5.5M Q1 '23: 6.2M Q2 '23: 6.6M Q3 '23: 6.9M Q4 '23: 7.1M Q1 '24: 7.2M Q2 '24: 7.3M Q3 '24: 7.2M Q4 '24: 7.2M Q1 '25: 7M Q2 '25: 7M Q3 '25: 6.8M Q4 '25: 6.8M Q1 '26: 6.7M Q2 '26: 6.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income TTM

-21M -14M -7M 0 7M 14M 21M Q3 '21: -19.1M Q4 '21: -18.4M Q1 '22: -16.8M Q2 '22: -15.7M Q3 '22: -13.6M Q4 '22: -6.8M Q1 '23: 430K Q2 '23: 1.7M Q3 '23: 2.1M Q4 '23: 3.4M Q1 '24: -3M Q2 '24: -2.5M Q3 '24: -2.4M Q4 '24: -2.2M Q1 '25: -1.6M Q2 '25: -1.1M Q3 '25: -1M Q4 '25: -470K Q1 '26: -799K Q2 '26: -969K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-18M -12M -6M 0 6M 12M 18M Q3 '21: -16M Q4 '21: -15.6M Q1 '22: -14.6M Q2 '22: -13.8M Q3 '22: -14.8M Q4 '22: -8.2M Q1 '23: -291K Q2 '23: 1.1M Q3 '23: 1.7M Q4 '23: 3.1M Q1 '24: -3.2M Q2 '24: -2.5M Q3 '24: -2.5M Q4 '24: -2.4M Q1 '25: -1.9M Q2 '25: -1.6M Q3 '25: -1.5M Q4 '25: -958K Q1 '26: -1.5M Q2 '26: -2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 5M 10M 15M Q3 '21: 11.1M Q4 '21: 11.4M Q1 '22: 12.2M Q2 '22: 12.3M Q3 '22: 11.7M Q4 '22: 10.7M Q1 '23: 9.7M Q2 '23: 9.1M Q3 '23: 9.2M Q4 '23: 8.9M Q1 '24: 8.7M Q2 '24: 8.5M Q3 '24: 8.4M Q4 '24: 8.5M Q1 '25: 8.3M Q2 '25: 8M Q3 '25: 7.6M Q4 '25: 7M Q1 '26: 6.7M Q2 '26: 6.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

-9M -6M -3M 0 3M 6M 9M Q3 '21: -7.8M Q4 '21: -7.5M Q1 '22: -6.2M Q2 '22: -4.3M Q3 '22: -3.3M Q4 '22: -1.9M Q1 '23: -531K Q2 '23: 2M Q3 '23: 2.6M Q4 '23: 2.3M Q1 '24: 760K Q2 '24: -708K Q3 '24: -811K Q4 '24: -861K Q1 '25: -424K Q2 '25: -80K Q3 '25: -217K Q4 '25: -407K Q1 '26: -225K Q2 '26: -492K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-12M -8M -4M 0 4M 8M 12M Q4 '18: 11.7M Q1 '19: 10.9M Q2 '19: 9.4M Q3 '19: 3.6M Q4 '20: -8.4M Q1 '21: -7.9M Q2 '21: -8.5M Q3 '21: -8.1M Q4 '21: -7.5M Q1 '22: -6.2M Q2 '22: -4.3M Q3 '22: -3.3M Q4 '22: -1.9M Q4 '24: -879K Q1 '25: -482K Q2 '25: -187K Q3 '25: -335K Q4 '25: -516K Q1 '26: -297K Q2 '26: -522K Q1 '19 Q4 '20 Q3 '21 Q2 '22 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 70M 140M 210M Q3 '19: 98.7M Q2 '20: 99.9M Q3 '20: 100M Q1 '21: 104.5M Q2 '21: 107.6M Q3 '21: 109.1M Q1 '22: 116.8M Q2 '22: 135.4M Q3 '22: 146.5M Q1 '23: 152.1M Q2 '23: 152.6M Q3 '23: 154.6M Q1 '24: 163.1M Q2 '24: 172.4M Q3 '24: 182.3M Q1 '25: 184.3M Q2 '25: 184.3M Q3 '25: 184.3M Q1 '26: 186.9M Q2 '26: 205.1M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.18 -0.12 -0.06 0.00 0.06 0.12 0.18 Q3 '21: -0.15 Q4 '21: -0.14 Q1 '22: -0.13 Q2 '22: -0.13 Q3 '22: -0.14 Q4 '22: -0.08 Q1 '23: -0.02 Q2 '23: -0.00 Q3 '23: 0.01 Q4 '23: 0.02 Q1 '24: -0.02 Q2 '24: -0.01 Q3 '24: -0.01 Q4 '24: 0.00 Q1 '25: 0.00 Q2 '25: 0.00 Q3 '25: 0.00 Q4 '25: -0.01 Q1 '26: -0.01 Q2 '26: -0.01 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.